Syn1-IRES-CreERT2
Nomenclature
C57BL/6JSmo-Syn1em1(IRES-CreERT2)Smoc
Cat. NO.
NM-KI-231789
Strain State
Repository Live
Gene Summary
Gene Symbol
Syn1
Model Description
Validation Data
Fig 1. Cre-mediated recombination in brain of Syn1CreERT2/+; Rosa26tdTomato/+ mice.
Fig 2. Cre-mediated recombination in brain of Syn1CreERT2/+; Rosa26tdTomato/+ mice.
Fig 3. Detection of tdTomato (red) in various tissues of Syn1CreERT2/+; Rosa26tdTomato/+ mice. Expression tissues include: brain, retina, islet, pituitary. A few cells expressed in spinal cord, heart, lung, liver, adrenal gland, kidney, small intestine, colon, muscle and thymus. Tissues that unexpressed include stomach, salivary glands, brown fat, spleen, uterus, skin. Tamoxifen induction began at 35 days of age, with testing at 45 days. (45-day old, female) (For more detailed information please contact our technical advisor.)
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
